Background
Methods
Data source
Patient selection and data
Comorbidity | ICD-10 codes |
---|---|
Pulmonary infection | J100, J110, J12–J18, J20–22, J85, J86, J690 |
Pulmonary aspergillosis | B44 |
COPD | J43, J440, J441, J449 |
Bronchial asthma | J45, J46 |
Interstitial lung disease | J841, J848, J849 |
Pneumothorax | J93 |
Congestive heart failure | I110, I500, I501, I509 |
Ischemic heart disease | I20–I25 |
Cerebrovascular disease | I60–I69 |
Renal disease | N00–08, N10–N19 |
Autoimmune disease | M05, M06, M08, M30–M35 |
Diabetes mellitus | E10–E14 |
Bone fracture | S02, S12, S22, S32, S42, S52, S62, S72, S82, S92, T02, T10, T12 |
Lung cancer | C33, C34 |
Hematological malignancy | C81–C85, C88, C90–C96 |
Other malignant disease | C00–C97 |
ICD-10 codes | |
---|---|
Hemorrhage from urinary system | N288, N300, N304, N309, N328, N368, N421, N421, N488, N501, E274 |
Hemorrhage associated with gynecological disease | N645, N830, N831, N838, N908, N921–N924, N930, N938, N939, N950, N988, O209, O441, O469, O679, O695, O720–O722, O730, O731 |
Hemorrhage associated with otolaryngological disease | E078, H603, H669, H738, H922, R040, R041 |
Intracerebral hemorrhage | I60–I62 |
Spinal cord hemorrhage | G951, G968 |
Ocular hemorrhage | H113, H168, H208, H210, H313, H350, H356, H357, H405, H431, H448, H470 |
Traumatic hemorrhage | S013, S051, S063, S066, S068, S098, S368, S378, T144, T794 |
Postoperative hemorrhage | T810, T811 |
Statistical analysis
Results
Patient characteristics
Total (%) | Death (%) | P-value | |||
---|---|---|---|---|---|
n = 16,192 | n = 3166 | ||||
Sex | < 0.001 | ||||
Male | 6283 | (38.8) | 1543 | (48.7) | |
Female | 9909 | (61.2) | 1623 | (51.3) | |
Age, years | < 0.001 | ||||
< 70 | 3400 | (21.0) | 455 | (14.4) | |
70–79 | 5374 | (33.2) | 1035 | (32.7) | |
≥ 80 | 7418 | (45.8) | 1676 | (52.9) | |
BMI, kg/m2 | < 0.001 | ||||
< 15.0 | 2858 | (17.7) | 910 | (28.7) | |
15.0–15.9 | 1627 | (10.0) | 371 | (11.7) | |
16.0–16.9 | 1714 | (10.6) | 297 | (9.4) | |
17.0–18.4 | 2533 | (15.6) | 365 | (11.5) | |
18.5–24.9 | 5036 | (31.1) | 568 | (17.9) | |
≥ 25.0 | 476 | (2.9) | 44 | (1.4) | |
Missing data | 1948 | (12.0) | 611 | (19.3) | |
Activities of daily living, Barthel index | < 0.001 | ||||
100 | 5137 | (31.7) | 354 | (11.2) | |
75–95 | 1553 | (9.6) | 159 | (5.0) | |
50–70 | 1921 | (11.9) | 336 | (10.6) | |
25–45 | 1225 | (7.6) | 296 | (9.3) | |
0–20 | 3818 | (23.6) | 1426 | (45.0) | |
Missing data | 2538 | (15.7) | 595 | (18.8) | |
Smoking history | < 0.001 | ||||
No | 11,373 | (70.2) | 2083 | (65.8) | |
Yes | 3167 | (19.6) | 668 | (21.1) | |
Missing data | 1652 | (10.2) | 415 | (13.1) | |
Symptom | |||||
Hemoptysis | 2996 | (18.5) | 528 | (16.7) | 0.003 |
Comorbidity | |||||
Pulmonary disease | |||||
Pulmonary infection | 8225 | (50.8) | 2024 | (63.9) | < 0.001 |
Pulmonary aspergillosis | 874 | (5.4) | 261 | (8.2) | < 0.001 |
COPD | 1527 | (9.4) | 362 | (11.4) | < 0.001 |
Bronchial asthma | 1158 | (7.2) | 181 | (5.7) | < 0.001 |
Interstitial lung disease | 1171 | (7.2) | 384 | (12.1) | < 0.001 |
Pneumothorax | 730 | (4.5) | 183 | (5.8) | < 0.001 |
Non-pulmonary disease | |||||
Congestive heart failure | 2279 | (14.1) | 650 | (20.5) | < 0.001 |
Ischemic heart disease | 1123 | (6.9) | 184 | (5.8) | 0.006 |
Cerebrovascular disease | 1248 | (7.7) | 243 | (7.7) | 0.94 |
Renal disease | 853 | (5.3) | 218 | (6.9) | < 0.001 |
Autoimmune disease | 1225 | (7.6) | 198 | (6.3) | 0.002 |
Diabetes mellitus | 2289 | (14.1) | 460 | (14.5) | 0.48 |
Bone fracture | 831 | (5.1) | 114 | (3.6) | < 0.001 |
Malignant disease | |||||
Lung cancer | 532 | (3.3) | 176 | (5.6) | < 0.001 |
Hematological malignancy | 234 | (1.4) | 71 | (2.2) | < 0.001 |
Other malignant disease | 1058 | (6.5) | 231 | (7.3) | 0.053 |
Treatments during hospitalization
Total (%) | Death (%) | P-value | |||
---|---|---|---|---|---|
n = 16,192 | n = 3166 | ||||
Medications prescribed during hospitalization | |||||
No use of NTM drugsa | 7215 | (44.6) | 1504 | (47.5) | < 0.001 |
Erythromycin only | 526 | (3.2) | 61 | (1.9) | < 0.001 |
RIF, EMB, CLR | 1676 | (10.4) | 232 | (7.3) | < 0.001 |
RIF, EMB, CLR, +FQ and/or AG | 778 | (4.8) | 188 | (5.9) | 0.001 |
Corticosteroidsb | 3383 | (20.9) | 1069 | (33.8) | < 0.001 |
Treatment procedure | |||||
Bronchial artery embolization | 250 | (1.5) | 22 | (0.7) | < 0.001 |
Mechanical ventilation | 1518 | (9.4) | 957 | (30.2) | < 0.001 |
All-cause in-hospital mortality
OR | 95% CI | P-value | |
---|---|---|---|
Sex | |||
Male | 1.89 | (1.70–2.10) | < 0.001 |
Age, years | |||
< 70 | reference | ||
70–79 | 1.12 | (0.98–1.29) | 0.11 |
≥ 80 | 1.04 | (0.90–1.20) | 0.56 |
BMI, kg/m2 | |||
< 15.0 | 3.15 | (2.74–3.62) | < 0.001 |
15.0–15.9 | 2.15 | (1.81–2.54) | < 0.001 |
16.0–16.9 | 1.57 | (1.31–1.87) | < 0.001 |
17.0–18.4 | 1.31 | (1.13–1.52) | < 0.001 |
18.5–24.9 | reference | ||
≥ 25.0 | 0.83 | (0.58–1.18) | 0.30 |
Activities of daily living, Barthel index | |||
100 | reference | ||
75–95 | 1.45 | (1.19–1.78) | < 0.001 |
50–70 | 2.58 | (2.18–3.06) | < 0.001 |
25–45 | 3.74 | (3.07–4.55) | < 0.001 |
0–20 | 7.72 | (6.68–8.92) | < 0.001 |
Smoking history | |||
Yes | 0.89 | (0.78–1.01) | 0.077 |
Symptom | |||
Hemoptysis | 1.21 | (1.07–1.37) | 0.002 |
Comorbidity | |||
Pulmonary disease | |||
Pulmonary infection | 1.70 | (1.54–1.87) | < 0.001 |
Pulmonary aspergillosis | 1.65 | (1.39–1.96) | < 0.001 |
COPD | 0.96 | (0.83–1.12) | 0.63 |
Bronchial asthma | 0.81 | (0.68–0.98) | 0.027 |
Interstitial lung disease | 2.77 | (2.37–3.24) | < 0.001 |
Pneumothorax | 1.40 | (1.14–1.73) | 0.001 |
Non-pulmonary disease | |||
Congestive heart failure | 1.62 | (1.43–1.83) | < 0.001 |
Ischemic heart disease | 0.79 | (0.66–0.95) | 0.011 |
Cerebrovascular disease | 0.75 | (0.63–0.88) | 0.001 |
Renal disease | 1.46 | (1.21–1.76) | < 0.001 |
Autoimmune disease | 0.85 | (0.72–1.01) | 0.072 |
Diabetes mellitus | 1.03 | (0.90–1.18) | 0.65 |
Bone fracture | 0.49 | (0.39–0.61) | < 0.001 |
Malignant disease | 2.07 | (1.79–2.39) | < 0.001 |